MORGAN SIEMER: Open Payments
NPI 1619502770 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 23 payments from 13 companies in 2025. Trend: 2023 $1,068 · 2024 $543 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $70 |
| Lilly USA, LLC | 3 | $53 |
| Exact Sciences Corporation | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| ABBVIE INC. | 2 | $34 |
| Amgen Inc. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Viatris Specialty LLC | 1 | $21 |
Products named: Kerendia, MOUNJARO, Ozempic, Cologuard Collection Kit, Wegovy, VOQUEZNA, GEMTESA, YUPELRI.
Industry payments across MO — which companies pay providers there.
